Plethico Pharmaceuticals, one of India’s fastest growing pharmaceutical companies in the herbal and nutraceuticals space having global presence, has opened for subscription today through 100% book building offer. The product range include herbal allopathic formulations,consumer healthcare products,food supplements,disposables,hospital consumables,vetenary products
Issue Terms:- Issue price / Floor Price (Rs) -280-300
Issue opens 10-Apr-06
Issue closes 17-Apr-06
Listing on BSE,NSE
Listing on BSE,NSE
Face Value-10
Minimum order quantity-20 shares
Plethico has two fully integrated state-of-the-art manufacturing units located near Indore, which serve as the backbone of the entire operations. These facilities are being upgraded as per stringent norms of UK MHRA.
For the year ended September 2005, it had a total gross block of Rs 115.51 crore (Rs 1.15 billion). It recorded total revenues of Rs 224.48 crore (Rs 2.24 billion) in 2004-05 and Rs 64.21 crore (Rs 642 million) for the quarter ended December 2005, with PAT of Rs 56.13 crore (Rs 561.3 million) and Rs 18.54 crore (Rs 185.4 million), respectively.
According to my opinion one can apply for this IPO for long term perspective.
No comments:
Post a Comment